ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Ulutas Med J. 2016; 2(2): 130-131


A Rare But Serious Entity: Corticosteroid Allergy

Ibrahim Koc, Ahmet Ulusan.



Abstract
Download PDF Cited by 1 ArticlesPost

Introduction: Systemic steroids are usually used in pulmonary medicine practise and are potential drugs in asthma less in chronic obstructive pulmonary disease (COPD) besides potential of allergy.
Case Presentation: We reported a sixty five years old man who had COPD for five years. The patient was hospitalised for COPD exacerbation and was treated with antibiotherapy plus bronchodilatory drugs. On the follow up when his symtoms did not decrease methyprednisolone was started. Ten minutes after the administration swelling, itchy and papuler skin lesions were observed all over the body particularly on the forearms. The patient was hospitalised a few times in the same clinic and was treated with methyprednisolone several times before but he had not experienced such a situation. Urticeria is charecterised with browned, swelling, itchy, edematous and papular lesions which tend to diseppear within 1-2 hours.
Conclusion: Corticosteroids seem to be rare causes of immediate hypersensitivity reactions which can be misdiagnosed. Physicians should be carefull and identify safe alternative preparations if needed.

Key words: Corticosteroid, allergy, COPD







Bibliomed Article Statistics

22
16
26
29
39
45
20
22
19
25
23
14
R
E
A
D
S

13

17

21

20

19

79

25

13

12

15

9

11
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.